Viscofan, S.a. · BME:VIS

Viscofan — Investor Presentation (2022)

50 slides from Viscofan's investor presentation, 2022

  1. Slide 1: Beyond25

    25 1

  2. Slide 2: Beyond25

    New purpose New “route to market” Beyond25 Operational transformation New organization 2025 targets 2

  3. Slide 3: New purpose

    Well Food New purpose being New “route to market” Operational transformation 3

  4. Slide 4: Reshaping food and wellbeing. For many, for long.

    Vis ci) fan Reshaping food and wellbeing. For many, for long.

  5. Slide 5: Reshaping food and wellbeing

    Reshaping food and wellbeing New purpose Strategic implication Our technology and our global presence allow us to be in a position to shape a better world. We contribute to improving access to food around the world, and we can also help through nutrition and our knowledge the well-being of human bei

  6. Slide 6: For many…

    For many… New purpose Strategic implication If something characterizes us, it is that we have always wanted to be relevant, to generate an impact, that is why our scope of action is the world, “for many”, the more people can enjoy our products, services or solutions, the better for our purpose. New

  7. Slide 7: For long

    For long New purpose Strategic implication And of course, we generate an impact that remains, a project for the future, a project that intends to be forever, "for long“. It is an impact for everyone, for life, for the well- being of all. This is our sustainable proposal. Sustainability as a transver

  8. Slide 8: Our strategic track record

    Our strategic track record New purpose MORE TO BE Be MORE Be ONE 2006-2011 2012-2015 2016-2021 “A strategy to benefit from our “A strategy to tackle the “A strategy to be the economies of scale” growth opportunity” authentic global leader, the casing company” Cost Technology Service Strategic pillar

  9. Slide 9: New plan: Profitable growth

    New plan: Profitable growth New purpose Sustainability as a strategic pillar Viscofan Group revenue* * Excludes revenue from divestments +7.0% +4.6% ≈8% +6.3% CAGR CAGR CAGR CAGR 416 565 741 969 1,300 2006 2011 2015 2021 2025e Be ONE Be MORE MORE TO BE Beyond25 Cost Technology Service Sustainability

  10. Slide 10: New “route to market”

    New purpose New “route to market” Operational transformation New organization 10

  11. Slide 11: Viscofan´s value proposal

    Viscofan´s value proposal Route to market Value chain Food Ingredients & casings Food Retailer Consumer company 11

  12. Slide 12: Positioning products in our purpose

    Positioning products in our purpose Route to market Bioengineering High added Season trasnfer value Collagen Satiating casings Edible films Hydrolyzates Functional ingredients Bags, films Veggie Cellulose casings casings Fibrous casings Interleavers Tubular plastic Developed Co-extrusion More to be

  13. Slide 13: New segmentation with two strategic approaches

    New segmentation with two strategic approaches Route to market Traditional Business (TB) New Business (NB) €809 Mn* €116 Mn* Edible films Bioengineering Veggie Hydrolyzates casings Collagen Satiating casings Netting Functional ingredients Tubular Interleavers Fibrous plastics Season trasnfer casings

  14. Slide 14: New segmentation with two strategic approaches

    New segmentation with two strategic approaches Route to market Traditional Business (TB) New Business (NB) Strengthen leadership Grow and gain size 20% 2% 14

  15. Slide 15: TB. Strengthen leadership

    Route to market TB. Strengthen leadership 15

  16. Slide 16: €4,000 million market, Traditional Business

    Route to market Cellulose Fibrous +5%/+7% Viscofan´s expected growth CAGRe 2022-2025 Traditional Collagen Business €4,000 million Emerging markets Market size Developed markets 16

  17. Slide 17: A market with strong growth fundamentals

    A market with strong growth fundamentals TENDENCIAS DE Route to market CRECIMIENTO Casings anual growth rate. volume +2%/+4% Collagen €1.0Bn FEEDING FOOD POPULATION HABITS Animal INDUSTRY gut Higher protein consumption Sophistication Population growth €2.1Bn More vegans and vegetarians Ensure the se

  18. Slide 18: Collagen

    Collagen Route to market ✓ New collagen extrusion and Viscofan: converting capacity to meet Tarjet in 2025 ✓ Natur casing promotion in expected demand Replace 5%-7% ✓ R&D: Development of new markets ✓ Investments in a technology of the animal gut new products to replace ✓ Specific projects by geogra

  19. Slide 19: Fibrous

    Fibrous Route to market Viscofan: Target in 2025 ✓ Spread growth to other emerging areas Market leadership in ✓ Installed capacity to be ✓ Portfolio adaptation in Europe this technology the world's largest and in the US ✓ Evolution of the new producer of fibrous technology Adapting portfolio Sharing

  20. Slide 20: Cellulose

    Cellulose Route to market Viscofan: ✓ Service and product improvement with the new Target in 2025 ✓ Installed capacity for a fast technology in Danville Cellulose adoption in response to growth ✓ Great opportunity to ✓ Learning and improvement new markets access protein in ✓ Global footprint, proxim

  21. Slide 21: Asia

    Asia Route to market Growth driver China South East Asia Actions: Actions: 1,400 Mn 580 Mn population • Help the market in its population • Prepared to supply quest for productivity market growth 0.2 € casing and automation 0.2 € casing per capita per capita • Increase presence • Expansion of collag

  22. Slide 22: Asia

    Asia Route to market Growth driver India. Develop the market Japón. Gain presence 1,400 Mn Actions: 125 Mn Actions: population population Develop the market Gain presence 0.0 € casing 0.7 € casing per capita Product launch (veggie per capita Commercial office and cellulose) since 2021 n.s. Developme

  23. Slide 23: SAM

    SAM Route to market Focus on volume South America 530 Mn population Actions: Supporting industry´s 0.4 € per capita sophistication process with more producto portfolio Number 1 Supporting our customers´productivity Growth potential in the region Production presence with the highest urban population

  24. Slide 24: Developed markets

    Developed markets Route to market Focus on value proposal North America Europe 500 Mn Actions: 750 Mn population population • Supporting customer 0.8 € casing 1.1 € casings automation and per capita per capita sustainability challenges Number 1 • Push and development of Number 1 snacking products Pr

  25. Slide 25: NB. Grow and gain size

    Route to market NB. Grow and gain size 25

  26. Slide 26: NB. Grow and gain size

    NB. Grow and gain size Route to market Approach to the use of collagen as Production process developed an ingredient in different based on technological leadership applications in casings and acquisitions Promotion of the value proposition Committed team with extensive to customers with new solution

  27. Slide 27: Cutting edge solutions

    Cutting edge solutions Route to market Edible films Collagen hydrolyzates Disruptive innovation to reach more markets Premium product Ingredients transfer Veggie casing Product to provide variety and help The only company in the world with efficiency a tubular product Industrialized process Applied

  28. Slide 28: >€5,000 million New Business addressable market

    Route to market Collagen hydrolyzates Veggie casing 15%/20% Viscofan´s expected growth CAGRe 2022-2025 New Edible film Business New generation plastics >€5,000 million Addressable market Bioengineering 28

  29. Slide 29: Collagen hydrolyzates

    Collagen hydrolyzates Route to market A Beyond25 growth opportunity Viscofan: ✓ Products release and ✓ Increase capacity in Germany Target in 2025. ✓ Production synergies with marketing Achieve 3% ✓ Extensive know-how on casings ✓ Strengthening commercial market share collagen ✓ Suppliers diversific

  30. Slide 30: Veggie casing

    Veggie casing Route to market A Beyond25 growth opportunity ✓ Currently less than 1% of sales Viscofan: although in more than 20 Target in 2025. ✓ Beyond. Set capacity in line countries. with market growth ✓ Beyond. Higher commercial 3% of Viscofan´s ✓ 2019-2021. Launch ✓ Seeking to industralize and

  31. Slide 31: ediLEAF

    ediLEAF Route to market A Beyond25 growth opportunity Ingredient. Edible film Product lines Application of herbs and/or spices in meat or fish Development: Product already developed and products. patented Transfer herbs and/or spices to dairy products, such as Operations: Planned investment in capac

  32. Slide 32: Plastics

    Plastics Route to market A Beyond25 growth opportunity Focus on circular economy Focus on added value eFAN Transfer casings Recycled or bio-based plastic casings helping A cost-effective alternative to conventional customers with their sustainability challenges smoking, frying or glazing of ham Cert

  33. Slide 33: Bioengineering

    Bioengineering Route to market Exploit our collagen know-how in the medical area Collagen gel Triankle Leading the for medical consortium applications Sales in the US and Italy Ardat Contribute to the development of advanced therapies GMP facility in Cardiomesh Germany Looking for patients 33

  34. Slide 34: Operational transformation

    New purpose New “route to market” Operational transformation New organization 2025 targets 34

  35. Slide 35: A lot of transformation projects

    A lot of transformation projects Operational transformation Capacity, efficiencies, digitalization y and sustainability as a basis Technology transfer Capacity and efficiencies “Driver to improve profitability” “Profitable growth” Beyond25 Digitalization Sustainability “As a source of competitive “S

  36. Slide 36: Technology transfer

    Technology transfer Operational transformation Seeking to improve the profitability in North America Automation Danville. Installation of a new technology in cellulose casings €25Mn More output Capex Better cost More reliability Better handling Better product quality 36

  37. Slide 37: Capacity increase

    Capacity increase Operational transformation To strengthen our leadership in collagen casings USA Higher production output thanks to the technological update in New Jersey Collagen. China Prepared to capture 7% of Increase extrusion and converting capacity animal gut market Adapt supply chain German

  38. Slide 38: Efficiencies

    Efficiencies Operational transformation Improve our industrial base and our supply chain Cellulose and fibrous technology in Cáseda Technoloy evolution and capacity utilization A more solid production SAM model to face any Maximize extrusion capacity environment China Suppliers diversification Adapt

  39. Slide 39: Digitalization

    Digitalization Operational transformation Source of competitive advantage Industrial model 5G network installation in Cáseda, artificial vision, machine learning, lone worker safety, remote expert, big data Efficiency and productivity Simplicity, BBDD HR Global, automation (robotics), partners integ

  40. Slide 40: Sustainability

    Sustainability Operational transformation Innovation for growth Product, process and new business models meeting sustanibility requirements Lead the industry in sustainability More solid business model, mitigate risks and take advantage of opportunities from climate change, anticipate regulation Par

  41. Slide 41: Sustainability

    Sustainability Operational transformation Viscofan. Contribution and priorities Global challeges In In In To feed a growing Climate Human process product people population change rights Sustainability as a new pillar of our strategy Viscofan. Prioritary SGGs New 41

  42. Slide 42: Sustainability

    Sustainability Operational transformation Water Waste to landfill Reduction of water withdrawal in m3 over Reduction of tonnes of waste sent to million of extruded meters landfill over million of extruded meters 100 93 70 -30% 100 95 90 -10% 2018 2021 2030 2018 2021 2030 Climate change Accident rate

  43. Slide 43: New organization

    New “route to market” Operational transformation New organization 2025 targets 43

  44. Slide 44: People

    People People New organization Our value Our lines of action Pioneers Enjoyment Diversity Resolutive Team players Health and safety Talent management Agility, transversal teams Motivation and commitment 44

  45. Slide 45: Organized to achieve our targets

    Organized to achieve our targets New organization José Antonio Canales CEO Jesús Calavia M. Carmen Peña Iñaki Goñi Chief Operations Chief Financial Chief Commercial Officer Officer Officer Andrés Díaz Gabriel Larrea Juan Negri Luis Bertoli CEO EMEA CEO NAM CEO APAC CEO SAM Spain United States China

  46. Slide 46: 2025 targets

    Operational transformation New organization 2025 targets 46

  47. Slide 47: A unique value proposal to achieve our Beyond25 ambition

    A unique value proposal to achieve our Beyond25 2025 targets ambition Margin €1.3Bn 26% €425Mn Revenue EBITDA Capex 2022-2025e 2025e margin 2025e US$/€: 1.15 47

  48. Slide 48: To wrap up

    To wrap up • The MORE TO BE strategic plan has been completed in 2021 with the best results in Viscofan´s history, exceeding our expected guidance for the year. • Higher volumes, improvement in price mix, production efficiencies and cost control counteract an adverse inflation environment. • Cash ge

  49. Slide 49: Appendix. Alternative Performance Measures

    Appendix. Alternative Performance Measures The Alternative Performance Measures included in this report are as follows: • The EBITDA, or operating profit before depreciation and • Net bank debt: This is calculated as non-current borrowings plus current amortization, is calculated excluding depreciat

  50. Slide 50: Disclaimer

    Disclaimer This document may include statements This circumstance must be taken into account about intentions, expectations or forecasts mainly for all persons or entities that may have to of the Company additional to the take decision, develop or spread opinions relative mandatory financial reporti

Viscofan — Investor Presentation (2022) on 6ix